Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma.
World Journal of Nuclear Medicine
We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.
Bartel, T., Yarbrough, T. L., & De Blanche, L. (2016). Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma.. World Journal of Nuclear Medicine, 15 (3). http://dx.doi.org/10.4103/1450-1147.172303